Evaluate Safety and Efficacy of a Single Treatment Cycle of EB-001 in Subjects With Glabellar Frown Lines
Clinical trial NCT02939326 · COMPLETED
Trial details
- NCT number
- NCT02939326
- Sponsor
- Bonti, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2017-07-12
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.